{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:15:35Z","timestamp":1784740535745,"version":"3.55.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2018,11,27]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Both statins and proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitors lower blood low-density lipoprotein cholesterol levels to reduce risk of cardiovascular events. To assess potential differences between metabolic effects of these 2 lipid-lowering therapies, we performed detailed lipid and metabolite profiling of a large randomized statin trial and compared the results with the effects of genetic inhibition of PCSK9, acting as a naturally occurring trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Two hundred twenty-eight circulating metabolic measures were quantified by nuclear magnetic resonance spectroscopy, including lipoprotein subclass concentrations and their lipid composition, fatty acids, and amino acids, for 5359 individuals (2659 on treatment) in the PROSPER (Prospective Study of Pravastatin in the Elderly at Risk) trial at 6 months postrandomization. The corresponding metabolic measures were analyzed in 8 population cohorts (N=72 185) using\n                      <jats:italic>PCSK9<\/jats:italic>\n                      rs11591147 as an unconfounded proxy to mimic the therapeutic effects of PCSK9 inhibitors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Scaled to an equivalent lowering of low-density lipoprotein cholesterol, the effects of genetic inhibition of PCSK9 on 228 metabolic markers were generally consistent with those of statin therapy (\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      =0.88). Alterations in lipoprotein lipid composition and fatty acid distribution were similar. However, discrepancies were observed for very-low-density lipoprotein lipid measures. For instance, genetic inhibition of PCSK9 had weaker effects on lowering of very-low-density lipoprotein cholesterol compared with statin therapy (54% versus 77% reduction, relative to the lowering effect on low-density lipoprotein cholesterol;\n                      <jats:italic>P<\/jats:italic>\n                      =2\u00d710\n                      <jats:sup>-7<\/jats:sup>\n                      for heterogeneity). Genetic inhibition of PCSK9 showed no significant effects on amino acids, ketones, or a marker of inflammation (GlycA), whereas statin treatment weakly lowered GlycA levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Genetic inhibition of PCSK9 had similar metabolic effects to statin therapy on detailed lipid and metabolite profiles. However, PCSK9 inhibitors are predicted to have weaker effects on very-low-density lipoprotein lipids compared with statins for an equivalent lowering of low-density lipoprotein cholesterol, which potentially translate into smaller reductions in cardiovascular disease risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/circulationaha.118.034942","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T12:35:43Z","timestamp":1546864543000},"page":"2499-2512","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":94,"title":["Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment"],"prefix":"10.1161","volume":"138","author":[{"given":"Eeva","family":"Sliz","sequence":"first","affiliation":[{"name":"Center for Life Course Health Research (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.), University of Oulu, Finland."},{"name":"Computational Medicine, Faculty of Medicine (E.S., J.K., Q.W., M.A.-K.), University of Oulu, Finland."},{"name":"Biocenter Oulu, Oulu, Finland (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Kettunen","sequence":"additional","affiliation":[{"name":"Center for Life Course Health Research (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.), University of Oulu, Finland."},{"name":"Computational Medicine, Faculty of Medicine (E.S., J.K., Q.W., M.A.-K.), University of Oulu, Finland."},{"name":"Biocenter Oulu, Oulu, Finland (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Holmes","sequence":"additional","affiliation":[{"name":"Medical Research Council Population Health Research Unit (M.V.H.), University of Oxford, United Kingdom."},{"name":"Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (M.V.H., R.W., K.L., I.Y.M., R.C., Z.C.), University of Oxford, United Kingdom."},{"name":"National Institute for Health Research, Oxford Biomedical Research Centre, Oxford University Hospital, United Kingdom (M.V.H.)."},{"name":"Medical Research Council Integrative Epidemiology Unit (M.V.H., D.A.L., M.A.-K., G.D.S.), University of Bristol, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare Oliver","family":"Williams","sequence":"additional","affiliation":[{"name":"MRC\/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (C.O.W., J.D., A.B.), University of Cambridge, United Kingdom."},{"name":"Homerton College (C.O.W.), University of Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Boachie","sequence":"additional","affiliation":[{"name":"Robertson Centre for Biostatistics (C.B., I.F.), University of Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Life Course Health Research (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.), University of Oulu, Finland."},{"name":"Computational Medicine, Faculty of Medicine (E.S., J.K., Q.W., M.A.-K.), University of Oulu, Finland."},{"name":"Biocenter Oulu, Oulu, Finland (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.)."},{"name":"Systems Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia (Q.W., M.A.-K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"M\u00e4nnikk\u00f6","sequence":"additional","affiliation":[{"name":"Northern Finland Birth Cohorts, Faculty of Medicine (M.M.), University of Oulu, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Sebert","sequence":"additional","affiliation":[{"name":"Center for Life Course Health Research (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.), University of Oulu, Finland."},{"name":"Biocenter Oulu, Oulu, Finland (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.)."},{"name":"Department of Genomics of Complex Diseases, School of Public Health, Imperial College London, United Kingdom (S.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Walters","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (M.V.H., R.W., K.L., I.Y.M., R.C., Z.C.), University of Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang","family":"Lin","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (M.V.H., R.W., K.L., I.Y.M., R.C., Z.C.), University of Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona Y.","family":"Millwood","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (M.V.H., R.W., K.L., I.Y.M., R.C., Z.C.), University of Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Clarke","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (M.V.H., R.W., K.L., I.Y.M., R.C., Z.C.), University of Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Li","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences, Beijing, China (L.L.)."},{"name":"Department of Global Health, School of Public Health, Peking University, Beijing, China (L.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Rankin","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences (N.R., P.W., C.D., N.S.), University of Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Welsh","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences (N.R., P.W., C.D., N.S.), University of Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Delles","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences (N.R., P.W., C.D., N.S.), University of Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[{"name":"Department of Cardiology (J.W.J., S.T.), Leiden University Medical Center, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Trompet","sequence":"additional","affiliation":[{"name":"Department of Cardiology (J.W.J., S.T.), Leiden University Medical Center, The Netherlands."},{"name":"Department of Internal Medicine, Section of Gerontology and Geriatrics (S.T.), Leiden University Medical Center, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[{"name":"Robertson Centre for Biostatistics (C.B., I.F.), University of Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Perola","sequence":"additional","affiliation":[{"name":"National Institute for Health and Welfare, Helsinki, Finland (M.P., V.S.)."},{"name":"Institute for Molecular Medicine Finland, University of Helsinki (M.P.)."},{"name":"University of Tartu, Estonian Genome Center, Estonia (M.P.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veikko","family":"Salomaa","sequence":"additional","affiliation":[{"name":"National Institute for Health and Welfare, Helsinki, Finland (M.P., V.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjo-Riitta","family":"J\u00e4rvelin","sequence":"additional","affiliation":[{"name":"Center for Life Course Health Research (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.), University of Oulu, Finland."},{"name":"Biocenter Oulu, Oulu, Finland (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.)."},{"name":"Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, Imperial College London, United Kingdom (M.R.-J.)."},{"name":"Unit of Primary Care, Oulu University Hospital, Oulu, Finland (M.R.-J.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (M.V.H., R.W., K.L., I.Y.M., R.C., Z.C.), University of Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie A.","family":"Lawlor","sequence":"additional","affiliation":[{"name":"Medical Research Council Integrative Epidemiology Unit (M.V.H., D.A.L., M.A.-K., G.D.S.), University of Bristol, United Kingdom."},{"name":"Population Health Science, Bristol Medical School (D.A.L., M.A-.K., G.D.S.), University of Bristol, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Ala-Korpela","sequence":"additional","affiliation":[{"name":"Center for Life Course Health Research (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.), University of Oulu, Finland."},{"name":"Computational Medicine, Faculty of Medicine (E.S., J.K., Q.W., M.A.-K.), University of Oulu, Finland."},{"name":"Biocenter Oulu, Oulu, Finland (E.S., J.K., Q.W., S.S., M.-R.J., M.A.-K.)."},{"name":"Medical Research Council Integrative Epidemiology Unit (M.V.H., D.A.L., M.A.-K., G.D.S.), University of Bristol, United Kingdom."},{"name":"Population Health Science, Bristol Medical School (D.A.L., M.A-.K., G.D.S.), University of Bristol, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Danesh","sequence":"additional","affiliation":[{"name":"MRC\/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (C.O.W., J.D., A.B.), University of Cambridge, United Kingdom."},{"name":"National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics (J.D., A.B.), University of Cambridge, United Kingdom."},{"name":"Wellcome Trust Sanger Institute, Hinxton, United Kingdom (J.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Davey Smith","sequence":"additional","affiliation":[{"name":"Medical Research Council Integrative Epidemiology Unit (M.V.H., D.A.L., M.A.-K., G.D.S.), University of Bristol, United Kingdom."},{"name":"Population Health Science, Bristol Medical School (D.A.L., M.A-.K., G.D.S.), University of Bristol, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences (N.R., P.W., C.D., N.S.), University of Glasgow, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Butterworth","sequence":"additional","affiliation":[{"name":"MRC\/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (C.O.W., J.D., A.B.), University of Cambridge, United Kingdom."},{"name":"National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics (J.D., A.B.), University of Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"W\u00fcrtz","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences (N.R., P.W., C.D., N.S.), University of Glasgow, United Kingdom."},{"name":"Diabetes and Obesity Research Program, University of Helsinki, Finland (P.W.). Nightingale Health Ltd, Helsinki, Finland (P.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31357-5"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61009-6"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60367-5"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500858"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501031"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664"},{"key":"e_1_3_4_8_2","article-title":"topline results alirocumab in patients after acute coronary syndrome.","author":"Schwartz GG","unstructured":"Schwartz, GG, Szarek, M, Bhatt, DL, Bittner, V, Diaz, R, Edelberg, J, Goodman, SG, Hanotin, C, Harrington, R, Jukema, JW, Lecorps, G, Moryusef, A, Pordy, R, Roe, M, White, HD, Zeiher, A, Steg, PG. The ODYSSEY OUTCOMES trial: topline results alirocumab in patients after acute coronary syndrome. American College of Cardiology \u2013 67th Scientific Sessions March 10, 2018; http:\/\/clinicaltrialresults.org\/Slides\/ACC2018\/ODYSSEY_Steg.pdf. Accessed March 17, 2018.","journal-title":"American College of Cardiology \u2013 67th Scientific Sessions March 10, 2018"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx450"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyg070"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054013"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604304"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.060"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.117.001759"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.085"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307995"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002224"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.10.028"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.01.004"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.02.044"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11600-X"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31928-1"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys066"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys064"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx239"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.271"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1214574110"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr120"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1076"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30396-5"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61183-1"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.114.000216"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013116"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1073"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11122"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx016"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.105551"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.09.007"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61177-6"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.1884"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612790"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007402"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005549"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2251"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.006"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx710"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.156"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.310882"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000168912.42941.60"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311015"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.01.022"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.118.034942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:35:28Z","timestamp":1715574928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.118.034942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":50,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018,11,27]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.118.034942"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.118.034942","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/278861","asserted-by":"object"}]},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"assertion":[{"value":"2018-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}